Market Summery
Acknowledging the impressive growth records, the market perceives currently, Market Research Future (MRFR) in its recently published study report asserts that the global Capillary Blood Collection Devices market size will register a staggering CAGR of 6.2% from 2022-2030, witnessing the accruals of approx. 790 Mn. USD by 2030.
The Capillary Blood Collection Devices Market has witnessed significant growth in recent years, driven by the increasing prevalence of chronic diseases and the growing demand for minimally invasive diagnostic procedures. Among the various devices in this market segment, capillary blood collection tubes play a pivotal role in the collection, storage, and transportation of blood samples. These tubes are designed to facilitate the collection of small blood volumes from capillaries, typically from a finger prick, making them particularly useful in settings where venous blood collection is challenging or impractical.
The demand for capillary blood collection tubes is fueled by their convenience, accuracy, and efficiency in point-of-care testing and remote healthcare settings. With advancements in technology, manufacturers are focusing on developing capillary blood collection tubes with improved features such as better compatibility with various analyzers, enhanced sample stability, and reduced risk of hemolysis. Additionally, the market is witnessing a surge in the adoption of capillary blood collection tubes in applications such as glucose monitoring, hemoglobin testing, and lipid profiling, further driving market growth. As healthcare systems continue to prioritize decentralized testing and remote patient monitoring, the Capillary Blood Collection Devices Market is expected to expand, with capillary blood collection tubes playing a crucial role in facilitating decentralized diagnostic testing and improving healthcare accessibility and efficiency.
Competitive Landscape of Capillary Blood Collection Devices Market:
The global market for capillary blood collection devices is characterized by intense competition and diversification, with major manufacturers operating on a global scale. These players are heavily investing in research and development, global expansion, advanced technologies, and product launches to gain a competitive edge in the market.
Key Players:
The market for capillary blood collection devices companies includes such as Danaher Corporation, Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Medtronic Plc., Novo Nordisk A S, Thermo Fisher Scientific Inc., Terumo Corporation, B. Braun Melsungen AG, HTL-STREFA S.A., Sarstedt AG & Co, Ypsomed Holding AG, Greiner Bio-One, Owen Mumford Ltd., Improve Medical, Nipro, Chengdu Rich Science Industry Co., Ltd., Weigao Group, Weihai Hongyu Medical Devices, and Medigard. MRFR has profiled these players and analyzed their strategies for maintaining a competitive position in the market.
Segments of Capillary Blood Collection Devices Market:
The analysis by MRFR is segmented into four key areas to facilitate the report and improve comprehension:
Materials: Including Glass, Plastic, and Stainless Steel, among others. Types of Devices: Encompassing Warming Devices, Blood Collecting Tubes & Collectors, and Lancets, among others. End-Users: Such as Hospitals, Clinics, Diagnostic Centers, Home Diagnostics, and Pathology Laboratories, among others. Regions: Covering North America, Europe, APAC, and Rest-of-the-World. Plastic is projected to dominate the materials segment, acquiring 42.3% of the market share, making it the largest share. This segment is expected to register a 10.4% CAGR during the period of 2017–2023.
The Blood Collecting Tubes and Collector segment is anticipated to hold the largest share based on types of devices, accounting for 48.4% of the market share over the review period.
The Lancets Segment is projected to grow at a CAGR of 10.4% between 2017–2023.
Regional Analysis of Capillary Blood Collection Devices Market:
North America leads the global capillary blood collection devices market, supported by established players and investments, holding the largest market share. Companies manufacturing these devices can provide customized solutions, and the region sees increased uptake of software solutions for healthcare administration, driving market growth.
Factors contributing to market growth include a rising number of patients with chronic diseases, demand for technologically advanced diagnosis and treatment, government support, and high per capita healthcare expenditures, with the market estimated to reach US$ 292.96 million by 2023.
Europe is the second-largest market for capillary blood collection devices globally, driven by technological advancements and increased adoption among healthcare providers, particularly in the UK, Germany, and France. Factors such as public and private funding for research and development, leading market players, and the prevalence of diabetes are expected to fuel market growth.
The Asia Pacific market is emerging as a promising market for capillary blood collection devices, driven by new diagnosis and treatment methods, increasing prevalence of chronic diseases like diabetes, and growing awareness about health management among the population. The APAC market is estimated to grow at a CAGR of 10.6% during 2017–2023.
The Middle East & Africa region is expected to experience a plateau in growth due to factors such as limited awareness, access, and availability of treatment facilities in the African market. However, the Middle East is expected to see steady growth due to its well-developed healthcare sector, particularly in countries like the UAE.
Related Reports-
For more information, Please Visit us @ Market Research Future
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)
Russian (русский)